期刊文献+

Cys-c和NAG联合检测在糖尿病肾病早期的诊断意义 被引量:9

The significance of detection on cysteine C and NAG in diagnosis of early diabetic nephropathy
下载PDF
导出
摘要 目的探讨半胱氨酸C(Cys-c)与N-乙酰-β-D-氨基葡萄糖苷酶(NAG)联合检测对糖尿病肾病早期的诊断意义。方法检测62例糖尿病患者(其中空腹血糖大于7.8mmol/L的患者35例作为血糖控制欠佳组,空腹血糖小于或等于7.8mmol/L的患者27例作为血糖控制良好组)的Cys-c、肌酐(Cr)、尿素氮(BUN)和NAG指标,同时随机选择65名健康体检者为对照组。结果糖尿病患者的血清中Cys-c和尿液中NAG与对照组比较均明显上升,差异有统计学意义(P<0.01);血糖控制良好组患者的Cys-c和NAG明显低于血糖控制欠佳组,差异有统计学意义(P<0.01)。结论 Cys-c和NAG联合检测对糖尿病肾病早期有重要的诊断价值。 Objective To explore the significance of detecting cysteine C(Cys-c) and N-acetyl-β-D-glucosaminidase(NAG)in diagnosis of early diabetic nephropathy.Methods The Cys-c,Cr,BUN and NAG indexes of 62 cases of diabetes(including 35 cases of fasting blood glucose 7.8 mmol/L patients as poorly controlled glycaemic group,and 27 cases of fasting blood glucose≤7.8 mmol/L patients as well controlled glycemic group) were detected.Meanwhile 65 healthy people were selected randomly as the control group.Results The Cys-c and NAG of diabetic group were significantly increased compared with the control group(P〈0.01).The Cys-c and NAG in the well-controlled group were significantly lower than those in the poorly controlled group(P〈0.01).Conclusion The combined detection of Cys-c and NAG in patients with early diabetic nephropathy has important diagnostic value.
出处 《检验医学与临床》 CAS 2013年第4期427-428,共2页 Laboratory Medicine and Clinic
关键词 半胱氨酸抑制剂C N-乙酰-Β-D-氨基葡萄糖苷酶 糖尿病肾病 Cystatin C N-acetyl-β-D-glucosaminidase diabetic nephropathy
  • 相关文献

参考文献8

二级参考文献40

共引文献173

同被引文献106

  • 1黄秀丽,张惠莉,高继东.血清胱抑素C在早期糖尿病肾病诊断中的价值[J].中国医学前沿杂志(电子版),2010,2(3):76-79. 被引量:6
  • 2徐守伟,刘冰冰,范刚.对糖尿病诊断标准的几点建议[J].山东医药,2007,47(14):62-62. 被引量:7
  • 3杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1188
  • 4美国糖尿病协会.2010年ADA糖尿病诊疗指南[M].糖尿病天地:临床刊,2010,4(2):56-65.
  • 5杨有业,张秀明.临床检验方法学评价[S].北京:人民卫生出版社,2008:48-51.
  • 6Schomig M,Eisenhandt A,Ritz E. The microinflam- matory state of uremia[J]. Blood Purif, 2000,18 (4) : 327-332.
  • 7Boer I H, Katz R, Cao J J,et al. Cystatin, albuminuria and mortality among older adults with diabetes[J]. Di- abetes Care ,2009,32(10): 1833-1838.
  • 8Mogensen C E. Management of early nephropathy in dia- betic patients[ J]. Annu Rev Med, 1995,46:79-93.
  • 9Hollenberg N K, Parving H H, Viberti G, et al. Albumi- nuria response to very high-dose valsartan in type 2 diabe- tes mellitus [ J ]. Hypertens, 2007,25 ( 9 ) : 1921-1926.
  • 10Rosario R F, Prabhakar S. Lipids and diabetic nephropa- thy[J]. Curr Diab Rep, 2006,6(6) :455-462.

引证文献9

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部